Hacker News new | past | comments | ask | show | jobs | submit login

Well that’s simply not true because pressure on Gilead has already made them agree to expire their exclusive rights to manufacture in the US by 2020.

It’s also not a rich vs poor country thing at all. It’s generic in almost all other parts of the world outside the US.




> generic in almost all other parts of the world outside the US.

in rich countries it s subsidized by generous healthcare contributions




Consider applying for YC's Spring batch! Applications are open till Feb 11.

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: